Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Sekisui Diagnostics

Download Mobile App





New Rapid COVID-19 Test Beats ELISA Method in Identifying SARS-CoV-2 Antibodies in Blood Within Just 12 Minutes

By HospiMedica International staff writers
Posted on 10 Feb 2021
A new rapid COVID-19 test to detect coronavirus antibodies beats the enzyme linked immunosorbent assay (ELISA) method in delivering results within just 12 minutes, marking a milestone in the development of immunological diagnostics.

An international research team involving the University of Paraná (Paraná, Brazil) and the University of Tübingen (Tübingen, Germany) has developed the new rapid test that can reliably identify COVID-19 antibodies in the blood within minutes. More...
The new process is based on a simple measuring principle, making it easy to carry out without expensive instruments and is therefore, suitable for use at mobile testing centers or by laboratories in less economically developed regions. The new diagnostic method is also far faster than the ELISA procedure, which for decades has been seen as the gold standard for laboratory diagnosis of antibodies.

The new test is based on magnetic nanoparticles that are coated with viral antigens. To conduct the test, blood serum or blood is applied to the test surface. After roughly two minutes, the nanoparticles are washed and treated with a developer reagent. If the blood sample displays antibodies to coronavirus, a color change occurs. While the traditional ELISA test produces results after about three hours, study results show that the new method only takes 12 minutes. Positive and negative results can be established simply with the naked eye, and by using additional instruments, such as a microplate reader, the precision of the test can be further increased. The total response time is 15 times shorter than that of the classic ELISA test, which means that hundreds of samples can be tested in just a few hours.

In addition, the study shows that the new technology can also be applied to the serological diagnosis of other diseases. There are no reports in research literature on an immunology test for COVID-19 that delivers data as quickly, as precisely and above all as cheaply. The researchers believe that it will be possible to offer the new test at a comparable price to the ELISA test in future.

“Only a small sample is needed for the test: a single drop that contains two microliters of serum is sufficient,” said the study’s lead author, Professor Luciano F. Huergo from the University of Paraná: “It’s also possible to use whole blood, in other words the separation of soluble blood components that is normally necessary can be omitted. It isn’t absolutely necessary to have a fully-equipped laboratory or use special equipment to carry it out.”

“Another advantage over the ELISA procedure is that the color result of our new procedure is directly proportional to the concentration of antibodies,” added Huergo. “In other words, the new method delivers data on the quantity of antibodies and not just whether any are present.”

Related Links:
University of Paraná
University of Tübingen



Gold Member
Handheld Blood Glucose Analyzer
STAT-Site
Hand-held Hemoglobin Analyzer
DiaSpect Tm
Surgical Dressing
ALLEVYN Ag+ SURGICAL
Vessel Sealing Instrument
ERGOseal
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Critical Care

view channel
Image: Masimo smartSET pulse oximetry with PPG AFib and OIRD Detection (Photo courtesy of Masimo)

Smart Pulse Oximetry Supports Earlier Recognition of Arrhythmias and Respiratory Risk

On general care floors, respiratory compromise and arrhythmias can develop between routine checks. Atrial fibrillation often goes undiagnosed in older adults, while opioid-induced respiratory depression... Read more

Surgical Techniques

view channel
Image: 3D-printed nitinol tapered flow-diverter stent with variable fiber density, sectional size and shape. (Photo courtesy of IMDEA Materials Institute)

3D Printing Method Could Enable More Flexible Cardiovascular Implants

Minimally invasive transcatheter devices must compress into small catheters and recover their intended shape after deployment, creating a design challenge for cardiovascular implants with complex, patient-specific... Read more

Patient Care

view channel
Image: Researchers evaluated the Omni 128 cm long-axial field-of-view PET/CT system, which captures more of the body and radiotracer signal at once, potentially enabling shorter scans. (Photo courtesy of GE HealthCare)

Total-Body PET/CT Scanner Enables One-Minute Diagnostic-Quality Cancer Imaging

Positron emission tomography/computed tomography (PET/CT) combines radiotracer-based functional imaging with anatomical detail to diagnose, stage, and monitor cancer. Conventional scanners image the body... Read more

Medical Imaging

view channel
Image: Visual Abstract (Sinuo Gao, Zhaoqi Zhang, Chao Shi, Cheng Cheng, Xindi Ma, Xinming Zhao, Yunjiang Liu Journal of Nuclear Medicine Oct 2026, 67 (10) 1552-1559; DOI: 10.2967/jnumed.125.271529)

Targeted PET/CT Predicts Early Treatment Response in HER2-Positive Breast Cancer

HER2-positive breast cancer is an aggressive subtype that accounts for a substantial proportion of breast cancer cases. Patients often receive neoadjuvant therapy before surgery to shrink tumors, but assessing... Read more

Point of Care

view channel
Image Credit: 123RF

Continuous Glucose Monitoring Identifies Cardiometabolic Risk in Adults Without Diabetes

Dysglycemia—abnormal blood glucose regulation—can fluctuate throughout the day and often escape conventional screening. Clinicians typically rely on fasting plasma glucose and hemoglobin A1c, which offer... Read more

Business

view channel
Image: Steris is expanding its healthcare consumables portfolio through an agreement to acquire Xodus Medical, a surgical products business focused on patient and operating room staff safety.

Steris to Expand Surgical Safety Portfolio With $2.1 Billion Xodus Medical Deal

Steris has signed a definitive agreement to acquire Xodus Medical, a specialty surgical products business based in Pennsylvania, for $2.1 billion at closing. The acquisition will expand Steris’s healthcare... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.